Sinopharm’s experimental mRNA jab is similar to more effective foreign vaccines and is designed to target the Omicron variant. Photo: Reuters
Sinopharm’s experimental mRNA jab is similar to more effective foreign vaccines and is designed to target the Omicron variant. Photo: Reuters
Coronavirus China
China /  Science

Covid-19: China’s Sinopharm mRNA vaccine approved for clinical trials

  • Experimental jab is similar to more effective foreign vaccines, will target Omicron variant
  • Drug maker says it could produce up to 2 billion doses a year

Hayley Wong
Hayley Wong

Updated: 7:20pm, 20 Jan, 2023

Why you can trust SCMP
Sinopharm’s experimental mRNA jab is similar to more effective foreign vaccines and is designed to target the Omicron variant. Photo: Reuters
Sinopharm’s experimental mRNA jab is similar to more effective foreign vaccines and is designed to target the Omicron variant. Photo: Reuters
READ FULL ARTICLE